Stock 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Equities

002864

CNE1000032C9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 20/05/2024 am IST 		5-day change 1st Jan Change
29.85 CNY +0.95% Intraday chart for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -0.33% -22.45%
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent drugs. The Company's main product is Panlong Qipian, which is for the treatment of orthopedic rheumatism diseases. The Company also provides other Chinese patent drugs for the treatment of hepatobiliary, cardiovascular and cerebrovascular, gynecological and anti-tumor diseases. The Company is also involved in the production and sales of Chinese herbal pieces, as well as the medical commercial distribution business. The Company distributes its products within domestic market.

Number of employees: 935

Sales per Business

CNY in Million2022Weight2023Weight Delta
Self-produced Chinese Patent Medicine
59.7 %
555 57.0 % 585 59.7 % +5.35%
Pharmaceutical Commercial Distribution
37.3 %
389 40.0 % 365 37.3 % -6.16%
Chinese Herbal Medicine
2.4 %
21 2.1 % 23 2.4 % +13.13%
Big Health Products
0.4 %
5 0.6 % 4 0.4 % -31.77%
Others
0.3 %
3 0.3 % 3 0.3 % -4.95%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
974 100.0 % 981 100.0 % +0.67%

Managers

Managers TitleAgeSince
Xiao Lin Xie CEO
 Chief Executive Officer 56 16/13/16
Feng Ming Zhu DFI
 Director of Finance/CFO 53 16/13/16
Jie Wu BRD
 Director/Board Member 54 16/13/16
Zhi Hong Zhang BRD
 Director/Board Member 60 16/13/16
Zhong Meng PRN
 Corporate Officer/Principal 41 01/08/01

Members of the board

Members of the board TitleAgeSince
Zhi Hong Zhang BRD
 Director/Board Member 60 16/13/16
Jie Wu BRD
 Director/Board Member 54 16/13/16
Xiao Lin Xie CEO
 Chief Executive Officer 56 16/13/16
Shui Ping Zhang BRD
 Director/Board Member 59 16/13/16
Xiao Feng Xie BRD
 Director/Board Member 48 16/13/16
Qing Shui Luo CHM
 Chairman 63 16/13/16
Zhong Meng PRN
 Corporate Officer/Principal 41 01/08/01
Wen Feng Zhu BRD
 Director/Board Member 54 10/18/10
Zhe Kun Chen BRD
 Director/Board Member 42 09/22/09
Hai Yun Ren BRD
 Director/Board Member 50 05/19/05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 107,407,360 62,927,578 ( 58.59 %) 1,126,400 ( 1.049 %) 58.59 %

Shareholders

NameEquities%Valuation
Guotai Asset Management Co., Ltd.
4.491 %
2,222,981 4.491 % 9 M ¥
GF Fund Management Co., Ltd.
2.452 %
1,213,520 2.452 % 5 M ¥
China Asset Management Co., Ltd.
2.081 %
1,029,873 2.081 % 4 M ¥
AXA-SPDB Investment Managers Co., Ltd.
1.852 %
916,908 1.852 % 4 M ¥
Bosera Asset Management Co., Ltd.
1.397 %
691,337 1.397 % 3 M ¥
Penghua Fund Management Co., Ltd.
1.142 %
565,100 1.142 % 2 M ¥
Wanjia Asset Management Co., Ltd.
1.030 %
509,714 1.030 % 2 M ¥
China Merchants Fund Management Co., Ltd.
0.9780 %
484,100 0.9780 % 2 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.9410 %
465,800 0.9410 % 2 M ¥
Great Wall Fund Management Co., Ltd.
0.8771 %
434,165 0.8771 % 2 M ¥

Company contact information

Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.

2801, Baliu 2nd Road Baqiao District

710025, Xi'an

+86 29 8333 8888

http://www.pljt.com
address Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
29.85 CNY
Average target price
41.72 CNY
Spread / Average Target
+39.77%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD Stock Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
-22.45% 431M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.15% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.81% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.60% 332B
ABBVIE INC. Stock AbbVie Inc.
+6.80% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.06% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.97% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002864 Stock
  4. Company Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW